How Much Is Imbruvica Without Insurance?

Brand vs. generic availability

Imbruvica is available only as a brand-name medication. A generic version of ibrutinib has received tentative FDA approval, but it isn’t commercially available. A generic could be released later in 2026, though. This would introduce more market competition.

Brand-name medications tend to cost more than generics. Prices reflect the time and investment required to research, develop, and test new treatments before they reach the market.

Dosage and quantity

Your prescribed Imbruvica dosage can play a meaningful role in what you pay each month. The medication comes in several formulations and doses. These include capsules (70 mg and 140 mg), tablets (140 mg, 280 mg, and 420 mg), and a 70 mg/mL liquid suspension.

The formulation you use and the amount of medication you fill at once can affect your cost.

Pharmacy

Imbruvica is usually dispensed through specialty pharmacies rather than standard retail pharmacies. Specialty pharmacies focus on high-cost and complex medications. They often coordinate delivery, insurance support, and patient assistance services.

Imbruvica is typically dispensed through a specialty pharmacy network set up by its manufacturer, Pharmacyclics. In most cases, your prescription will be filled by one of these designated pharmacies. Because of this, you may have fewer choices about where to fill it, and what you pay can vary depending on which specialty pharmacy handles your prescription.

Insurance coverage

Your out-of-pocket cost for Imbruvica largely depends on whether you have insurance and what your plan includes. Some plans cover the medication. Others may require extra steps first, such as prior authorization or step therapy. Prior authorization means your insurer needs to approve the prescription before it’s covered. Step therapy means you may need to try lower-cost treatments before switching to Imbruvica.

If you don’t have insurance, you may be responsible for the full price unless you’re able to use a savings program.

Ask your prescriber about lower-cost alternatives

If Imbruvica isn’t affordable, a cancer specialist may recommend a medication such as Brukinsa (zanubrutinib) or Calquence (acalabrutinib). These medications work in a similar way to Imbruvica, but their prices and insurance coverage can differ.

Other treatment approaches may also be available depending on your specific condition. Blood cancer care is highly individualized, so your cancer care team can help you compare the benefits, risks, and costs of each option and choose the one that works best for your situation.

1. See if you qualify for a copay savings card

The Imbruvica ByYourSide program can significantly lower out-of-pocket costs for people with commercial insurance. Eligible enrollees can pay as little as $0 per prescription (up to the program’s annual maximum).

To qualify for this manufacturer copay savings card, you should:

• Have commercial insurance that covers Imbruvica

• Live in the U.S. or a U.S. territory

• Have a valid Imbruvica prescription for an FDA-approved use

You can see if you’re eligible for the program by filling out a quick online form. You can also call the manufacturer at 1-855-332-6210 or ask your cancer care team or specialty pharmacy to help you enroll.

You aren’t eligible for this option if you are uninsured or receive benefits through Medicare, Medicaid, Tricare, the Veterans Affairs, or another government-funded program.

2. Check if you’re eligible for a patient assistance program

If you don’t qualify for the copay card or can’t afford Imbruvica, you may be able to receive the medication at no cost through the manufacturer’s patient assistance program, myAbbVie Assist.

This program is meant for people who don’t have insurance — or whose coverage isn’t enough — and need help paying for their medication. To be eligible, you typically need to meet income requirements, live in the U.S. or a U.S. territory, and have a valid prescription for an approved use. You’ll also need to submit documentation, such as proof of income and insurance information if you have coverage.

You can apply online or by faxing an application form to 1-866-286-6024. Your cancer care team will also need to submit an application form on your behalf.

Good to know: Independent patient assistance programs may also be able to help. Many of them offer assistance for certain blood cancer medications, including Imbruvica. Examples include the PAN Foundation and The Assistance Fund.

3. Ask about longer-term supplies

Imbruvica comes in different package sizes depending on the formulation and dose you’re prescribed. For example, the capsules and tablets are often dispensed in quantities of 28 or 90 pills. The liquid form comes in a bottle holding 108 mL of medication.

In some cases, getting a 2- or 3-month supply may help lower your overall cost and cut down on pharmacy deliveries. Many specialty medications are delivered by mail.

Your cancer care team or specialty pharmacy can help you check if your insurance allows larger fills and whether it’s a good option for you. Not everyone will qualify for extended supplies. Some insurance plans limit how much you can fill at once, especially for newer medications or prescriptions that may need dose changes. It also may not make sense depending on where you are in your cancer treatment.

4. Tap into your HSA, FSA, or HRA

If you have a health savings account (HSA), a flexible spending account (FSA), or a health reimbursement arrangement (HRA), you can use those tax-free dollars to cover the cost of Imbruvica.

FSA funds are valid for a limited time. So you should use your FSA funds by the end of the plan year, before they expire. HSA funds work differently — they roll over each year and can be used anytime. HRA funds may or may not roll over, depending on the plan.

Why trust our experts?

Written by:

Joshua Murdock, PharmD, BCBBS

Joshua Murdock, PharmD, BCBBS, is a licensed pharmacist in Arizona, Colorado, and Rhode Island. He has worked in the pharmacy industry for more than 10 years and currently serves as a pharmacy editor for GoodRx.

Reviewed by:

Christina Aungst, PharmD

Christina Aungst, PharmD, is a pharmacy editor for GoodRx. She began writing for GoodRx Health in 2019, transitioning from freelance writer to editor in 2021.

Our editorial standards

Meet our experts